I’m a sleep and pulmonary medicine doctor who focuses on sleep disorders and cystic fibrosis. I believe that many factors contribute to health, and my part in managing a disease is to improve as many pieces of my patients’ health as I can.
The unique perspective children have on life and medicine inspired me to pursue my career. I find their outlook exciting and working with children brought so much joy and fun to my job that I couldn't pass it up. I want my patients to look forward to our appointments. I also want them to find it is an opportunity for them to be heard and have autonomy in their care.
In 2018, I was recognized with the Courage to Teach award by The Ohio State University. This award is for those who demonstrate a passion for medical education and commitment to teaching. I really enjoy working with residents and students, so this award was particularly meaningful to me.
With our teams’ research, we're studying the impact of certain pulmonary diseases on sleep and mental/behavioral health. We're also looking into how mental and behavioral health may affect our ability to keep patients as healthy as possible.
In my free time, I love to spend time with my family and travel!
MD: The Ohio State University College of Medicine, Columbus, OH, 2013.
Residency: Nationwide Children's Hospital, Columbus, OH, 2016.
Fellowship: Pediatric Pulmonology, Nationwide Children's Hospital, Columbus, OH, 2019; Sleep Medicine, The Ohio State University Wexner Medical Center/Nationwide Children's Hospital, Columbus, OH, 2020.
Pulmonary medicine; sleep medicine; cystic fibrosis
Pulmonary Medicine, Cystic Fibrosis Center
Mental and behavioral health impacts on pulmonary and sleep disorders
Pulmonary Medicine
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Growth, Body Composition, and Strength of Children With Cystic Fibrosis Treated With Elexacaftor/Tezacaftor/Ivacaftor (ETI). Pediatric Pulmonology. 2025; 60:e27463.
Improving implementation and team communication by integrating a cystic fibrosis transition readiness (CF R.I.S.E.) program into electronic health records. Pediatric Pulmonology. 2025; 60:e27326.
161 Is a multidisciplinary, family-focused intervention to improve BMI, body composition, and related functions for preadolescents treated with elexacaftor/tezacaftor/ivacaftor feasible?. Journal of Cystic Fibrosis. 2024; 23:s90.
555 School is in session: development of a comprehensive toolkit for care teams to support school success. Journal of Cystic Fibrosis. 2024; 23:s306.
779 Transition: a multidisciplinary approach. Journal of Cystic Fibrosis. 2024; 23:s448.
Body composition in children with cystic fibrosis treated with CFTR modulators versus modulator naïve individuals. Pediatric Pulmonology. 2024; 59:805-808.
Education-related needs for children with cystic fibrosis: Perspectives of US pediatric care teams. Pediatric Pulmonology. 2024; 59:95-100.
Cystic Fibrosis. Pediatric Rotations. : Springer Nature; Springer Nature; 2024.
Longitudinal mental health trends in cystic fibrosis. Journal of Cystic Fibrosis. 2023; 22:1093-1099.
123 Rates of change in growth, body composition, muscle strength, and FEV1 during elexacaftor-tezacaftor-ivacaftor therapy for 6- to 11-yearold children. Journal of Cystic Fibrosis. 2023; 22:s64-s65.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey